January 13, 2023
Via: PharmaphorumThe green light for the pre-filled, single-use pen version of Tezspire (tezepelumab) comes just four months after the TSLP inhibitor became the first biologic therapy for severe asthma to be cleared in the EU for use in all patients, and […]
May 11, 2021
Via: PMLiVEAZ and Amgen are seeking approval for tezepelumab for the treatment of severe asthma patients, based on results from the companies’ PATHFINDER clinical programme. This includes data from the pivotal phase 3 NAVIGATOR trial, which demonstrated that tezepelumab achieved a […]
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
September 14, 2023
August 30, 2023
September 20, 2023
Copyright © 2023. All rights reserved
